EVEROLIMUS
Everolimus is an mTOR inhibitor used in cancer therapy and transplant immunosuppression. Side effects include mouth ulcers, infections, and hyperglycemia.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of Action
Everolimus is an mTORC1 inhibitor derived from sirolimus. It binds FKBP‑12, forming a complex that inhibits mTORC1 signalling, suppressing protein synthesis, cell growth, angiogenesis and metabolic regulation. It is widely used in oncology and immunomodulation research.
Benefits and Advantages
Used in mTOR‑pathway modelling, tumour‑growth inhibition studies, angiogenesis‑suppression research, and immunosuppressive signalling assays.
Side Effects and Risks
Risks include stomatitis, hyperglycemia, hyperlipidemia, immunosuppression, pneumonitis and delayed wound healing. Handle with mTOR‑inhibitor precautions.
Datasheet
| Molecular Formula | C53H83NO14 |
|---|---|
| Molecular Weight | 958.2 g/mol |
| CAS Number | 159351-69-6 |
| Storage Condition | Conditions for safe storage, including any incompatibilities: Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature: -20 °C. Store under inert gas. |
| Solubility | Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance. |
| Purity | Purity information is available upon request (COA). |
| Synonym | Everolimus; Afinitor; Certican; 159351-69-6; SDZ-RAD |
| IUPAC/Chemical Name | (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone |
| InChl Key | HKVAMNSJSFKALM-GKUWKFKPSA-N |
| InChl Code | InChI=1S/C53H83NO14/c1-32-16-12-11-13-17-33(2)44(63-8)30-40-21-19-38(7)53(62,68-40)50(59)51(60)54-23-15-14-18-41(54)52(61)67-45(35(4)28-39-20-22-43(66-25-24-55)46(29-39)64-9)31-42(56)34(3)27-37(6)48(58)49(65-10)47(57)36(5)26-32/h11-13,16-17,27,32,34-36,38-41,43-46,48-49,55,58,62H,14-15,18-26,28-31H2,1-10H3/b13-11+,16-12+,33-17+,37-27+/t32-,34-,35-,36-,38-,39+,40+,41+,43-,44+,45+,46-,48-,49+,53-/m1/s1 |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

